Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Hess

Showing results (461-470 of 543) with videos related to

Pageof 55
Sort By:
Vaccine|June 2, 1998
Protection of mice against SV40 tumours by Pam3Cys, MTP-PE and Pam3Cys conjugated with the SV40 T antigen-derived peptide, K(698)-T(708)M Obert, H Pleuger, H G Hanagarth, et al.
Biorxiv : the Preprint Server for Biology|February 6, 2026
Mismatch repair MLH complexes make distinct contributions to post-replicative mismatch repair versus trinucleotide repeat expansionsKatherine M Casazza, Greg M Williams, Lauren Johengen, et al.
Transplantation|April 15, 1995
Extrahepatic synthesis of C6 in the rat is sufficient for complement-mediated hyperacute rejection of a guinea pig cardiac xenograftR B Brauer, T T Lam, D Wang, et al.
Stem Cells Translational Medicine|March 16, 2017
Assessment of Drug Sensitivity in Hematopoietic Stem and Progenitor Cells from Acute Myelogenous Leukemia and Myelodysplastic Syndrome Ex VivoKatherine L B Knorr, Laura E Finn, B Douglas Smith, et al.
Transplantation Proceedings|December 1, 1987
Regeneration of genetically restricted immune functions after human bone marrow transplantation: influence of four different strategies for graft-v-host disease prophylaxisA D Donnenberg, A D Hess, S C Duff, et al.
Oncogene|November 19, 2008
PML tumor suppressor is regulated by HIPK2-mediated phosphorylation in response to DNA damageE Gresko, S Ritterhoff, J Sevilla-Perez, et al.
Oncology|April 22, 2008
Capecitabine and vinorelbine as first-line treatment in elderly patients (> or =65 years) with metastatic breast cancer. A phase II trial (SAKK 25/99)D Hess, D Koberle, B Thurlimann, et al.
Lancet (London, England)|April 8, 1989
Induction of graft-versus-host disease after autologous bone marrow transplantationR J Jones, G B Vogelsang, A D Hess, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1995
Characterization of the autoreactive T cell repertoire in cyclosporin-induced syngeneic graft-versus-host disease. A highly conserved repertoire mediates autoaggressionA C Fischer, P P Ruvolo, R Burt, et al.
Journal of Animal Science|March 7, 2013
Investigation of sainfoin (Onobrychis viciifolia) cultivar differences on nitrogen balance and fecal egg count in artificially infected lambsB N Azuhnwi, H Hertzberg, Y Arrigo, et al.
Pageof 55

Showing results (461-470 of 543) with videos related to

Sort By:
Pageof 55
Vaccine|June 2, 1998
Protection of mice against SV40 tumours by Pam3Cys, MTP-PE and Pam3Cys conjugated with the SV40 T antigen-derived peptide, K(698)-T(708)M Obert, H Pleuger, H G Hanagarth, et al.
Biorxiv : the Preprint Server for Biology|February 6, 2026
Mismatch repair MLH complexes make distinct contributions to post-replicative mismatch repair versus trinucleotide repeat expansionsKatherine M Casazza, Greg M Williams, Lauren Johengen, et al.
Transplantation|April 15, 1995
Extrahepatic synthesis of C6 in the rat is sufficient for complement-mediated hyperacute rejection of a guinea pig cardiac xenograftR B Brauer, T T Lam, D Wang, et al.
Stem Cells Translational Medicine|March 16, 2017
Assessment of Drug Sensitivity in Hematopoietic Stem and Progenitor Cells from Acute Myelogenous Leukemia and Myelodysplastic Syndrome Ex VivoKatherine L B Knorr, Laura E Finn, B Douglas Smith, et al.
Transplantation Proceedings|December 1, 1987
Regeneration of genetically restricted immune functions after human bone marrow transplantation: influence of four different strategies for graft-v-host disease prophylaxisA D Donnenberg, A D Hess, S C Duff, et al.
Oncogene|November 19, 2008
PML tumor suppressor is regulated by HIPK2-mediated phosphorylation in response to DNA damageE Gresko, S Ritterhoff, J Sevilla-Perez, et al.
Oncology|April 22, 2008
Capecitabine and vinorelbine as first-line treatment in elderly patients (> or =65 years) with metastatic breast cancer. A phase II trial (SAKK 25/99)D Hess, D Koberle, B Thurlimann, et al.
Lancet (London, England)|April 8, 1989
Induction of graft-versus-host disease after autologous bone marrow transplantationR J Jones, G B Vogelsang, A D Hess, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1995
Characterization of the autoreactive T cell repertoire in cyclosporin-induced syngeneic graft-versus-host disease. A highly conserved repertoire mediates autoaggressionA C Fischer, P P Ruvolo, R Burt, et al.
Journal of Animal Science|March 7, 2013
Investigation of sainfoin (Onobrychis viciifolia) cultivar differences on nitrogen balance and fecal egg count in artificially infected lambsB N Azuhnwi, H Hertzberg, Y Arrigo, et al.
Pageof 55